Saving Lives at Birth Democratic Republic of the Congo NeoBeat Study 2017

Description

NeoBeat is a low-cost, battery-operated newborn HR monitor designed by Laerdal Global Health (LGH) that detects HR accurately, quickly (<5 seconds), is reusable, and can be easily disinfected using locally-available methods. A single provider can apply NeoBeat in 2-3 seconds and use it to identify a heart rate (HR) after birth in a non-breathing newborn and guide further management, including bag-mask ventilation. Its HR measurement accuracy level is short term average ±10% or ±5 bpm, whichever is greater. This device could be used to incorporate HR throughout the Helping Babies Breath (HBB) algorithm to improve newborn resuscitation in LMICs, but it had not yet been tested in this application. In this study, we evaluated the change in total stillbirths comparing care prior to HBB training (Epoch 1) to implementation of HBB with NeoBeat (Epoch 2) and HR-guided HBB (Epoch 3). Additionally, we evaluated the change in effective breathing at three minutes comparing HBB with NeoBeat to HR-guided HBB.

Resources

Name Format Description Link
21 The Newborn Heart Rate as a Catalyst for Improved Survival (NeoBeat Study) enrolled participants born between 1/1/17 and 06/22/20. The primary purpose of this prospective, population-based observational study is to provide complementary data to the "LIVEBORN" electronic tablet app data collected to track data from the Neobeat heartrate device. Three health facilities in Kinshasa, the Democratic Republic of the Congo participated in the study. This dataset includes demographics information collected at the maternal level, Screening, Demographics, and Outcomes form. https://datahub.usaid.gov/d/sem9-7kcv
21 The Newborn Heart Rate as a Catalyst for Improved Survival (NeoBeat Study) enrolled participants born between 1/1/17 and 06/22/20, with observational data collection beginning October 25, 2018. The primary purpose of this study was to evaluate the effect of resuscitation training and continuous electronic heart rate monitoring on total stillbirths. Three health facilities in Kinshasa, the Democratic Republic of the Congo participated in the study. This dataset includes the observational data collected via an electronic tablet application, “LIVEBORN”, to document delivery room resuscitations. https://datahub.usaid.gov/d/keq9-chgt
21 The Newborn Heart Rate as a Catalyst for Improved Survival (NeoBeat Study) enrolled participants born between 1/1/17 and 06/22/20. The primary purpose of this prospective, population-based observational study is to provide complementary data to the "LIVEBORN" electronic tablet app data collected to track data from the Neobeat heartrate device. Three health facilities in Kinshasa, the Democratic Republic of the Congo participated in the study. This dataset includes demographics information collected at the maternal level, Screening, Demographics, and Outcomes form. https://data.usaid.gov/d/sem9-7kcv
21 The Newborn Heart Rate as a Catalyst for Improved Survival (NeoBeat Study) enrolled participants born between 1/1/17 and 06/22/20, with observational data collection beginning October 25, 2018. The primary purpose of this study was to evaluate the effect of resuscitation training and continuous electronic heart rate monitoring on total stillbirths. Three health facilities in Kinshasa, the Democratic Republic of the Congo participated in the study. This dataset includes the observational data collected via an electronic tablet application, “LIVEBORN”, to document delivery room resuscitations. https://data.usaid.gov/d/keq9-chgt

Tags

  • neonatal-resuscitation
  • helping-babies-breathe
  • heart-rate
  • babies
  • infant
  • neonatal-mortality
  • congo-kinshasa

Topics

Categories